Efficacy News and Research

RSS
14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

IDRI's TB vaccine protects against drug-resistant tuberculosis

IDRI's TB vaccine protects against drug-resistant tuberculosis

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Cempra to present data on solithromycin, TAKSTA at 48th Annual Meeting in Vancouver

Cempra to present data on solithromycin, TAKSTA at 48th Annual Meeting in Vancouver

FDA plans to revoke knee implant approval following intense political pressure for its approval

FDA plans to revoke knee implant approval following intense political pressure for its approval

PTC announces ataluren Phase 2b efficacy data at International Congress

PTC announces ataluren Phase 2b efficacy data at International Congress

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Genentech and Biogen Idec announce positive results from ocrelizumab phase II RRMS study

Genentech and Biogen Idec announce positive results from ocrelizumab phase II RRMS study

NovaBay to present two poster presentations at IDSA Annual Meeting

NovaBay to present two poster presentations at IDSA Annual Meeting

Startech, STRCIC invest $2.5 million in ViroXis Corporation

Startech, STRCIC invest $2.5 million in ViroXis Corporation

FibroGen announces initiation of FG-3019 phase 2 study for reversing liver fibrosis

FibroGen announces initiation of FG-3019 phase 2 study for reversing liver fibrosis

Genzyme reports five-year patient data from Phase 2 multiple sclerosis trial

Genzyme reports five-year patient data from Phase 2 multiple sclerosis trial

VertiFlex enrolls patients in Superion IDE clinical trial

VertiFlex enrolls patients in Superion IDE clinical trial

IsoRay initiates study of Cesium-131 brachytherapy seeds for NSCLC cancer

IsoRay initiates study of Cesium-131 brachytherapy seeds for NSCLC cancer

Workshop to focus on FDA process that grants orphan drug designation

Workshop to focus on FDA process that grants orphan drug designation

NIH awards grant to Bavarian to advance early research in filoviruses

NIH awards grant to Bavarian to advance early research in filoviruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.